Home/Filings/4/0001104659-24-073006
4//SEC Filing

Faulkner Robert C. 4

Accession 0001104659-24-073006

CIK 0001769804other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 9:31 PM ET

Size

7.0 KB

Accession

0001104659-24-073006

Insider Transaction Report

Form 4
Period: 2024-06-14
Transactions
  • Award

    Common Stock

    2024-06-14+12,87941,461 total
Footnotes (3)
  • [F1]On June 14, 2024 (the "Grant Date"), at the election of Mr. Faulkner, the reported shares of the Common Stock were issued in lieu of cash compensation that Mr. Faulkner is entitled to receive for his services as a member of the Issuer's Board of Directors for Q2 2024 based on the closing price of the Common Stock on the Grant Date. The reported shares are fully vested and unrestricted, subject to the terms and conditions set forth in the Issuer's 2020 Equity Incentive Plan.
  • [F2]The securities were granted to Mr. Faulkner in connection with his service as a member of the Board of Directors of the Issuer. Mr. Faulkner, a managing director of Redmile Group, LLC ("Redmile"), was elected to the board of the Issuer as a representative of Redmile and its affiliates. Pursuant to the policies of Redmile, Mr. Faulkner holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Faulkner disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Faulkner is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  • [F3]The securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Issuer

Augmedix, Inc.

CIK 0001769804

Entity typeother

Related Parties

1
  • filerCIK 0001831991

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:31 PM ET
Size
7.0 KB